GD Pharma is an experienced pharmaceuticals company in South Australia that is GMP/TGA compliant to cultivate and produce medicinal cannabis in Australia.
The majority of cannabis companies in Australia are startups that are growing into the market. GD Pharma is the exception with its world’s state-of-the-art research, cultivation and production facilities.
Leveraging its experience and credibility, GD Pharma has released its popular “GD Cann-C” and “GD Cann-T” medicinal cannabis products in Australia. With many medical practitioners still adjusting to the legal medical cannabis changes, GD Pharma provides medical-grade products that meet the highest standards for patient consumption.
Quality Control is critical for medical cannabis products in Australia. Ensuring consistent quality to gain the confidence of medical professionals and patients in this growing industry.
Antony Condina, CEO, has extensive experience in the pharmaceutical industry in Australia. Since 2010, Antony has dedicated himself to improving the lives of patients by providing modern, higher quality and innovative pharmaceutical products.
Disclaimer: Cannabis Place may contain information regarding cannabis & other drugs; it is designed for 18+ audiences in regions where cannabis has been decriminalised. This topic may represent illegal activity in certain regions. We do not encourage illegal activity. We understand that readers in locations where cannabis has been legalised may read these articles. Medical Cannabis in Australia is regulated by the Therapeutic Goods Administration and details about Cannabis as a scheduled drug can be found on their website. Please consult with your doctor to find out if Cannabis is right for you. Click here for our full disclaimer
Tasmanian Botanics is a family-owned and runs cannabis cultivation, production and research company. Their focus is to utilise Tasmania's clean environment and their modern cultivation facility to produce medical-grade cannabis for Australian and international distribution.